For research use only. Not for therapeutic Use.
AC-263093 (Cat No.: I040090) is a selective small-molecule inhibitor that targets specific receptors or signaling pathways involved in cell growth and survival, particularly in cancer research. It is most commonly studied for its potential to modulate androgen receptor (AR) signaling, making it a candidate for the treatment of prostate cancer and other androgen-dependent cancers. AC-263093 works by interfering with the binding of androgen to its receptor, disrupting downstream signaling involved in tumor cell proliferation. Preclinical studies suggest it may be a promising therapeutic for these cancers.
| CAS Number | 849459-86-5 |
| Synonyms | 2-[(E)-(3,4-dibromophenyl)methylideneamino]guanidine |
| Molecular Formula | C8H8Br2N4 |
| Purity | ≥95% |
| InChI | InChI=1S/C8H8Br2N4/c9-6-2-1-5(3-7(6)10)4-13-14-8(11)12/h1-4H,(H4,11,12,14)/b13-4+ |
| InChIKey | VMYFCUKMGMFQNH-YIXHJXPBSA-N |
| SMILES | C1=CC(=C(C=C1C=NN=C(N)N)Br)Br |
| Reference | [1]. David H Malin, et al. Reversal of morphine tolerance by a compound with NPFF receptor subtype-selective actions. Neurosci Lett. 2015 Jan 1:584:141-5. |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
